Alissa A. Chackerian

Author

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

A. Chackerian, Alissa A Chackerian, Alissa A. Chackerian, Alissa Chackerian

Publications

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Harvard University Brigham and Women's Hospital

About

Alissa A. Chackerian is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, immunology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	476
2	Immunology	4	4	476
3	Cell Biology	2	2	393
4	Allergy	1	1	179
5	Microbiology	1	1	72

Alissa A. Chackerian

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
IL-1 Receptor Accessory Protein and ST2 Comprise the IL-33 Receptor Complex Alissa A. Chackerian, Elizabeth R. Oldham, Erin E. Murphy, The Journal of Immunology	2007	504
Dissemination of<i>Mycobacterium tuberculosis</i>Is Influenced by Host Factors and Precedes the Initiation of T-Cell Immunity Alissa A. Chackerian, Jennifer Alt, Thushara V. Perera, Infection and Immunity	2002	399
Dinaciclib induces immunogenic cell death and enhances anti-PD1–mediated tumor suppression Dewan Md Sakib Hossain, Sarah Javaid, Mingmei Cai, Journal of Clinical Investigation ApoptosisImmunologyImmunoeditingCell DeathCheckpoint Inhibitor	2018	214
Activation of NKT Cells Protects Mice from Tuberculosis Alissa A. Chackerian, Jen Alt, Vaji Perera, Infection and Immunity Adaptive Immune SystemInnate Immune SystemImmune RegulationImmunologyImmunologic Mechanism	2002	179
Gamma Interferon-Producing CD4<sup>+</sup>T Lymphocytes in the Lung Correlate with Resistance to Infection with<i>Mycobacterium tuberculosis</i> Alissa A. Chackerian, Thushara V. Perera, Samuel M. Behar Infection and Immunity	2001	175
Protective Immunity to Systemic Infection with Attenuated <i>Salmonella enterica</i> serovar Enteritidis in the Absence of IL-12 Is Associated with IL-23-Dependent IL-22, but Not IL-17 Silke M. Schulz, Gabriele Köhler, Nicole Schütze, The Journal of Immunology	2008	115
Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer Ruth Perets, Jair Bar, Drew Rasco, Annals of Oncology	2020	80
Neutralization or Absence of the Interleukin-23 Pathway Does Not Compromise Immunity to Mycobacterial Infection Alissa A. Chackerian, Shi‐Juan Chen, Scott J. Brodie, Infection and Immunity Bcg InfectionMicrobial PathogensImmunologyMycobacterial Bcg InfectionInflammation	2006	72
The LFA-1 Adhesion Molecule Is Required for Protective Immunity during Pulmonary <i>Mycobacterium tuberculosis</i> Infection Shamik Ghosh, Alissa A. Chackerian, Christina M. Parker, The Journal of Immunology	2006	56
Antitumor efficacy of combined CTLA4/PD-1 blockade without intestinal inflammation is achieved by elimination of FcγR interactions David Bauché, Smita Mauze, Christina M. Kochel, Journal for ImmunoTherapy of Cancer	2020	23

Page 1